Phase I Clinical Trial of GRID Therapy in Pediatric Osteosarcoma of the Extremity

Conditions:Other Indications
Therapuetic Areas:Other
Age Range:5 - 21
Start Date:July 25, 2017
End Date:June 2020
Contact:Sandy Annis, BA

Use our guide to learn which trials are right for you!

The primary objective of this study is to evaluate the toxicity profile of GRID therapy using
dose levels of 10Gy, 15 Gy and 20Gy in pediatric osteosarcoma of the extremity.

Subjects will receive GRID radiotherapy. GRID radiation therapy is considered a standard
radiation therapy method however is not typically used in pediatric osteosarcoma patients.
This protocol will evaluate whether or not the use of this therapy will provide benefit to
this patient population.

Inclusion Criteria:

- History of cytological or histological documentation of non-metastatic extremity

- 5-21 years of age.

- Subject is eligible for routine chemotherapy and routine surgery for the treatment of
non-metastatic extremity osteosarcoma

- Informed consent is obtained

Exclusion Criteria:

- Females with a positive urine pregnancy test.

- Unable to comply with study procedures
We found this trial at
529 West Markham Street
Little Rock, Arkansas 72205
(501) 686-7000
Phone: 501-686-7284
University of Arkansas for Medical Sciences The University of Arkansas for Medical Sciences (UAMS) in...
Little Rock, AR
Click here to add this to my saved trials